Predictive Pooling Strategy: Global Biotech Company Reduces Risk in Downstream Purification

Article

Sponsored Content

Read this case study on a large global biotechnology company that was looking to explore predictive models to improve the yield of their downstream bioprocess using historical data.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.